期刊文献+

阿司匹林对PICC置管后血浆中D-二聚体水平及静脉炎发生率的影响 被引量:5

The Effect of Aspirin on the D-dimer Level in Plasma and Incidence of Phlebitis After PICC
下载PDF
导出
摘要 目的评估阿司匹林对中心静脉导管(PICC)置入后静脉炎的预防作用。方法将110例接受PICC置管的肿瘤患者,按有否使用阿司匹林分为两组。观察组:58例,PICC置管后,除给予常规PICC导管护理外,采用阿司匹林预防PICC置管后静脉炎形成;对照组:52例,PICC置管后,仅给予常规PICC导管护理。对比两组患者血浆中D-二聚体水平及静脉炎的发生情况。结果观察组和对照组血浆中D-二聚体水平,置管前后分别为:(0.86±0.09)mg/L、(0.89±0.10)mg/L(P>0.05)和(1.01±0.10)mg/L、(3.28±0.31)mg/L,(P<0.01);静脉炎的发生率分别为:5.2%和26.9%(P<0.01),对照组有2例(3.8%)发生血栓。结论阿司匹林能有效降低PICC置管后血浆中D-二聚体水平和静脉炎的发生率。 Objective To evaluate The effect of Aspirin t on the D- dimer level in plasma and the incidence of phlebitis after central venous catheter( PICC). Methods 110 cases of the tumors adopted the PICC were divided into two groups,according to with or not use of aspirin. Observation group( n =58),besides routine care for PICC,aspirin is used to prevent phlebitis after PICC; Control group( n =52),routine care only after PICC. And then compare the D- dimer level in plasma and the incidence rate of phlebitis in two groups. Results The level of D- dimer in plasma of observation group is( 0. 86± 0. 09) mg / L、( 0. 89 ± 0. 10) mg / L respectively,P 0. 05,and control group is( 1. 01 ± 0. 10)mg / L、( 3. 28 ± 0. 31) mg / L respectively,P 0. 01,before and after PICC. The incidence of phlebitis is respectively 5. 2% vs 26. 9%(P〈0. 01) of observation group and control group. 2 cases of blood clots in the control group. Conclusion Aspirin can effectively reduce the level of D- dimer in plasma and the incidence of phlebitis after PICC.
机构地区 清远市人民医院
出处 《广东微量元素科学》 CAS 2015年第8期45-48,共4页 Trace Elements Science
关键词 阿司匹林 PICC D-二聚体 静脉炎 血栓 aspirin PICC D-dimer phlebitis blood clots
  • 相关文献

参考文献6

二级参考文献25

共引文献78

同被引文献40

  • 1杨文琴.评估拜阿司匹林对经外周静脉置入中心静脉导管肿瘤患者相关性血栓的预防作用[J].中国药物经济学,2013,8(S1):424-425. 被引量:5
  • 2Olson JD.D-dimer: An overview of hemostasis and fibrinolysis,assays,and clinical applications[J].Adv Clin Chem,2015,69:1-46.
  • 3Caine GJ,Stonelake PS,Lip GY,et al.The hypercoagulable state of malignancy:Pathogenesis and current debate[J].Neoplasia,2002,4(6):465-473.
  • 4Blackwell K,Haroon Z,Broadwater G,et al.Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status[J].J Clin Oncol,2000,18(3):600-608.
  • 5Ay C,Dunkler D,Pirker R,et al.High D-dimer levels are associated with poor prognosis in cancer patients[J].Haematologica,2012,97(8):1158-1164.
  • 6Lippi G,Franchini M,Targher G,et al.Help me,Doctor! My D-dimer is raised[J].Ann Med,2008,40(8):594-605.
  • 7Pan L,Zhao Q,Yang X.Risk factors for venous thrombosis associated with peripherally inserted central venous catheters[J].Int J Clin Exp Med,2014,7(12):5814-5819.
  • 8Schutgens RE,Haas FJ,Biesma DH.Reduced effi cacy of clinical probability score and D-dimer assay in elderly subjects suspected of having deep vein thrombosis[J].Br J Haematol,2005,129(5): 653-657.
  • 9Lyman GH,Eckert L,Wang Y,et al.Venous thromboembolism risk in patients with cancer receiving chemotherapy:A real-world analysis[J].Oncologist,2013,18(12):1321-1329.
  • 10Inal T,Anar C,Polat G,et al.The prognostic value of D-dimer in lung cancer[J].Clin Respir J,2015,9(3):305-313.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部